DK1553977T3 - Vaccine mod infektioner med onkogene vira, såsom Felin Leukæmi Virus hos katte - Google Patents
Vaccine mod infektioner med onkogene vira, såsom Felin Leukæmi Virus hos katteInfo
- Publication number
- DK1553977T3 DK1553977T3 DK03773451T DK03773451T DK1553977T3 DK 1553977 T3 DK1553977 T3 DK 1553977T3 DK 03773451 T DK03773451 T DK 03773451T DK 03773451 T DK03773451 T DK 03773451T DK 1553977 T3 DK1553977 T3 DK 1553977T3
- Authority
- DK
- Denmark
- Prior art keywords
- felin
- cats
- leukemia virus
- vaccine against
- against infections
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241000282324 Felis Species 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 241000282326 Felis catus Species 0.000 title 1
- 208000032839 leukemia Diseases 0.000 title 1
- 231100000590 oncogenic Toxicity 0.000 title 1
- 230000002246 oncogenic effect Effects 0.000 title 1
- 108010052285 Membrane Proteins Proteins 0.000 abstract 1
- 102000018697 Membrane Proteins Human genes 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 101710172711 Structural protein Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000021601 lentivirus infection Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10244863 | 2002-09-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1553977T3 true DK1553977T3 (da) | 2006-11-27 |
Family
ID=32038184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03773451T DK1553977T3 (da) | 2002-09-23 | 2003-09-19 | Vaccine mod infektioner med onkogene vira, såsom Felin Leukæmi Virus hos katte |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7915035B2 (enExample) |
| EP (1) | EP1553977B1 (enExample) |
| JP (1) | JP4411213B2 (enExample) |
| AT (1) | ATE335507T1 (enExample) |
| AU (1) | AU2003281917A1 (enExample) |
| DE (2) | DE10393824D2 (enExample) |
| DK (1) | DK1553977T3 (enExample) |
| ES (1) | ES2270120T3 (enExample) |
| WO (1) | WO2004028562A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0901593D0 (en) * | 2009-01-30 | 2009-03-11 | Touchlight Genetics Ltd | Production of closed linear DNA |
| US20130197612A1 (en) | 2010-02-26 | 2013-08-01 | Jack W. Lasersohn | Electromagnetic Radiation Therapy |
| GB201013153D0 (en) | 2010-08-04 | 2010-09-22 | Touchlight Genetics Ltd | Primer for production of closed linear DNA |
| RS58289B1 (sr) * | 2011-07-20 | 2019-03-29 | Merial Ltd | Rekombinantna vakcina protiv virusa mačje leukemije koja sadrži optimizovani gen omotača virusa mačje leukemije |
| JP7731670B2 (ja) * | 2017-11-06 | 2025-09-01 | インターベット インターナショナル ベー． フェー． | ネコ白血病ウイルスワクチン |
| EP3706788A1 (en) | 2017-11-06 | 2020-09-16 | Intervet International B.V. | Feline leukemia virus vaccine |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU607399B2 (en) * | 1985-09-09 | 1991-03-07 | Cetus Corporation | Infectious recombinant virus vaccine for feline leukemia |
| EP0575491B1 (en) * | 1991-03-07 | 2003-08-13 | Virogenetics Corporation | Genetically engineered vaccine strain |
| FR2751223B1 (fr) * | 1996-07-19 | 1998-12-04 | Rhone Merieux | Formule de vaccin polynucleotidique felin |
| DE19648625A1 (de) * | 1996-11-13 | 1998-05-14 | Soft Gene Gmbh | Mikroprojektil für das Einbringen von Substanzen in Zellen durch ballistischen Transfer |
| US6696291B2 (en) * | 1997-02-07 | 2004-02-24 | Merck & Co., Inc. | Synthetic HIV gag genes |
| US6248582B1 (en) * | 1997-10-08 | 2001-06-19 | Imran Khan | Gene deleted recombinant FeLV proviral DNA for production of vaccines against FeLV |
| SE9803099D0 (sv) * | 1998-09-13 | 1998-09-13 | Karolinska Innovations Ab | Nucleic acid transfer |
| CN1564867B (zh) * | 2001-10-02 | 2010-05-12 | 莫洛根股份公司 | 治疗利什曼原虫感染的dna表达构建体 |
-
2003
- 2003-09-19 WO PCT/DE2003/003179 patent/WO2004028562A2/de not_active Ceased
- 2003-09-19 AT AT03773451T patent/ATE335507T1/de active
- 2003-09-19 DE DE10393824T patent/DE10393824D2/de not_active Expired - Fee Related
- 2003-09-19 AU AU2003281917A patent/AU2003281917A1/en not_active Abandoned
- 2003-09-19 EP EP03773451A patent/EP1553977B1/de not_active Expired - Lifetime
- 2003-09-19 JP JP2004538747A patent/JP4411213B2/ja not_active Expired - Fee Related
- 2003-09-19 DE DE50304603T patent/DE50304603D1/de not_active Expired - Lifetime
- 2003-09-19 DK DK03773451T patent/DK1553977T3/da active
- 2003-09-19 ES ES03773451T patent/ES2270120T3/es not_active Expired - Lifetime
- 2003-09-23 US US10/528,748 patent/US7915035B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE10393824D2 (de) | 2005-08-11 |
| US20060240034A1 (en) | 2006-10-26 |
| ATE335507T1 (de) | 2006-09-15 |
| AU2003281917A1 (en) | 2004-04-19 |
| US7915035B2 (en) | 2011-03-29 |
| WO2004028562A3 (de) | 2004-06-03 |
| EP1553977A2 (de) | 2005-07-20 |
| WO2004028562A2 (de) | 2004-04-08 |
| AU2003281917A8 (en) | 2004-04-19 |
| EP1553977B1 (de) | 2006-08-09 |
| DE50304603D1 (de) | 2006-09-21 |
| JP4411213B2 (ja) | 2010-02-10 |
| JP2006511211A (ja) | 2006-04-06 |
| ES2270120T3 (es) | 2007-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122841T1 (el) | Πολυαλκυλενικες πολυμερικες ενωσεις και χρησεις αυτων | |
| NO20051969L (no) | Nukleosidderivater for behandling av hepatitt C virusinfeksjon. | |
| CY1119241T1 (el) | Ιοσωματια aav με μειωμενη ανοσοαντιδραστικοτητα και χρησεις αυτων | |
| CY1109667T1 (el) | Εμβολιο για προληψη και θεραπεια της λοιμωξης - hiv | |
| DE69535125D1 (de) | Impstoff gegen felines immunodefizienz-virus | |
| ATE542137T1 (de) | Immunocytokine mit modulierter selektivität | |
| EA200600498A1 (ru) | Макроциклические пептиды, проявляющие противовирусную активность в отношении вируса гепатита с | |
| ECSP093601A (es) | Proteínas derivadas del virus del síndrome de mancha blanca y sus usos | |
| WO2005013918A3 (en) | Compositions, methods and kits relating to poxvirus subunit vaccines | |
| DE69938935D1 (de) | Zyklische conotoxin-peptide | |
| CY1109675T1 (el) | Αντιμικροβιακα πολυπεπτιδια | |
| DK0652287T3 (da) | Poxvirale vektorer og deres anvendelse som en vaccine mod felin infektiøs peritonotos-virussygdom | |
| DK0661999T3 (da) | Vacciner mod felint immundefekt virus (FIV) | |
| WO2010041241A3 (en) | Hiv-1 integrase derived stimulatory peptides interfering with integrase - rev protein binding | |
| ATE543513T1 (de) | Anti-coronavirus impfstoff | |
| AU2003281917A8 (en) | Vaccine against infections caused by oncoviruses such as the feline leucosis virus of cats | |
| ATE294857T1 (de) | Impfstoff gegen infektionen mit lentiviren, wie dem felinen immunschwäche-virus der katze | |
| CY1109023T1 (el) | Gm-αρνητικα μεταλλαγματα ehv | |
| CY1109206T1 (el) | gM- ΑΡΝΗΤΙΚΟΙ EHV-ΜΕΤΑΛΛΑΚΤΕΣ ΧΩΡΙΣ ΕΤΕΡΟΛΟΓΑ ΣΤΟΙΧΕΙΑ | |
| HK1046911A1 (zh) | 经稳定的病毒外膜蛋白质及其使用 | |
| DK0778894T3 (da) | Vaccine mod infektiös felin peritonitis | |
| WO2004071462A3 (en) | Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction | |
| ATE521640T1 (de) | Anti-tsg101-antikörper und ihre verwendungen bei der behandlung von virusinfektionen | |
| NO20024325D0 (no) | Rensede hepatitt C-viruskappeproteiner for diagnostisk og terapeutisk anvendelse | |
| ATE476197T1 (de) | Rekombinante vakzine gegen infektion mit dem japanischen enzephalitis-virus äjevü und verfahren davon |